To Improve Adverse Event Tracking, FDA Could Google It
This article was originally published in The Rose Sheet
Executive Summary
Teleconference between Google and FDA signals the internet search giant could have a way to improve adverse-event detection. The agency calls the talk “a high-level, general discussion” of Google’s capabilities.